Sudarshan Pharma Industries Limited

SUDARSHAN

INE00TV01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:51 29/05/2024 BST			5-day change	1st Jan Change
64.48 ^INR	-1.33%		-3.75%	-20.68%

04-01	Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer	CI
03-30	1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	CI

Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit

July 27, 2023 at 03:00 pm

Sudarshan Pharma Industries Limited (BSE:543828) to consider acquisition of Ratna Lifesciences as unit.

Latest news about Sudarshan Pharma Industries Limited

Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer	04-01	CI
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	03-29	CI
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	03-28	CI
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023	12-12	CI
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director	12-12	CI
Sudarshan Pharma Industries Limited Announces Board Changes	11-10	CI
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023	15/09/23	CI
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company	18/08/23	CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023	10/08/23	CI
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million.	08/08/23	CI
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit	27/07/23	CI
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023	21/07/23	CI
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director	21/07/23	CI
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director	19/06/23	CI
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million.	16/03/23	CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/12/22	CI
Sudarshan Pharma Industries Limited has filed an IPO.	09/12/22	CI

Chart Sudarshan Pharma Industries Limited

Duration

Period

Chart Sudarshan Pharma Industries Limited

More charts

Sudarshan Pharma Industries Limited is an India-based company, which is engaged in job work manufacturing in pharmaceutical items and traders in chemicals and solvents in India. The Company operates in the State of Maharashtra, Gujarat, Himachal Pradesh, and Uttarakhand. The Company is involved in specialty chemicals and intermediates for pharma, agriculture chemicals, coating, paints, adhesive, and various other industries. It is also into active pharmaceuticals ingredients manufacturing. It is also into specialty chemicals imports and exports, as well as supply of same to the actual users. The Company provides customize specialty chemicals to its clients in India and abroad regularly. The Company is also involved in contract manufacturing, outsource and supply of generic pharma formulation, and medicines to healthcare institution, government, non-governmental organization (NGO) and hospitals.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SUDARSHAN PHARMA INDUSTRIES LIMITED	-20.68%	18.9M
ELI LILLY AND COMPANY	+38.00%	727B
NOVO NORDISK A/S	+30.75%	592B
JOHNSON & JOHNSON	-7.60%	347B
MERCK & CO., INC.	+15.72%	319B
ABBVIE INC.	+0.51%	274B
ASTRAZENECA PLC	+12.19%	238B
NOVARTIS AG	+6.85%	204B
ROCHE HOLDING AG	-5.85%	203B
PFIZER, INC.	-3.25%	160B